ID   HF3309
AC   CVCL_C8PU
DR   Wikidata; Q123031664
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 625 hours (PubMed=32064048).
CC   Sequence variation: Mutation; HGNC; 5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=32064048; DOI=10.18632/oncotarget.27457; PMCID=PMC6996910;
RA   Ye L.F., Reznik E., Korn J.M., Lin F., Yang G.-Z., Malesky K., Gao H.,
RA   Loo A., Pagliarini R., Mikkelsen T., Lo D.C., deCarvalho A.C.,
RA   Stockwell B.R.;
RT   "Patient-derived glioblastoma cultures as a tool for small-molecule
RT   drug discovery.";
RL   Oncotarget 11:443-451(2020).
//